Edition:
United Kingdom

Bausch Health Companies Inc (BHC.TO)

BHC.TO on Toronto Stock Exchange

29.39CAD
23 Aug 2019
Change (% chg)

$-0.01 (-0.03%)
Prev Close
$29.40
Open
$29.08
Day's High
$29.45
Day's Low
$29.08
Volume
69,401
Avg. Vol
700,150
52-wk High
$36.52
52-wk Low
$23.60

About

Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology... (more)

Overall

Beta: -0.36
Market Cap(Mil.): $5,024.01
Shares Outstanding(Mil.): 347.33
Dividend: --
Yield (%): --

Financials

  BHC.TO Industry Sector
P/E (TTM): -- 29.89 32.67
EPS (TTM): -3.27 -- --
ROI: -2.83 14.89 14.48
ROE: -24.78 16.01 15.78

Amag's female libido injectable therapy to sell at $899

Amag Pharmaceuticals Inc's treatment to boost sexual desire in premenopausal women will be offered at $899 and is the only injectable drug on the market for hypoactive sexual desire disorder (HSDD).

06 Aug 2019

UPDATE 1-Amag's female libido injectable therapy to sell at $899

Aug 6 Amag Pharmaceuticals Inc's treatment to boost sexual desire in premenopausal women will be offered at $899 and is the only injectable drug on the market for hypoactive sexual desire disorder (HSDD).

06 Aug 2019

Amag's female libido injectable therapy to sell at $899

Aug 6 Amag Pharmaceuticals Inc's treatment to boost sexual desire in premenopausal women will be offered at $899 and is the only injectable drug on the market for the condition.

06 Aug 2019

Bausch Health's lotion for plaque psoriasis wins FDA approval

The U.S. Food and Drug Administration on Thursday approved Bausch Health Companies Inc's topical plaque psoriasis treatment, which is expected to be a key revenue driver for the company.

25 Apr 2019

UPDATE 1-Bausch Health's lotion for plaque psoriasis wins FDA approval

April 25 The U.S. Food and Drug Administration on Thursday approved Bausch Health Companies Inc's topical plaque psoriasis treatment, which is expected to be a key revenue driver for the company.

25 Apr 2019

Bausch Health's lotion for plaque psoriasis wins FDA approval

April 25 Bausch Health Companies Inc said on Thursday the U.S. Food and Drug Administration has approved its lotion for plaque psoriasis in adults.

25 Apr 2019

U.S. FDA loosens alcohol restrictions for female libido pill

The U.S. Food and Drug Administration said on Thursday women taking Sprout Pharmaceuticals Inc's female libido pill, Addyi, need not completely avoid alcohol.

11 Apr 2019

U.S. FDA loosens alcohol restrictions for female libido pill

April 11 The U.S. Food and Drug Administration said on Thursday women taking Sprout Pharmaceuticals Inc's female libido pill, Addyi, need not completely avoid alcohol.

11 Apr 2019
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates